Stay updated on Pembrolizumab and Radiation in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page
- ChecktodayChange DetectedThe page’s footer revision label was updated from **v3.5.2** to **v3.5.3**, reflecting a non-clinical version update of the page display.SummaryDifference0.0%

- Check7 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No substantive content changes to the study details are indicated by the provided inputs.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check36 days agoChange DetectedRevision: v3.5.0 replaces the previous v3.4.3 on the page. No obvious changes to the study data or core content are indicated.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision update from v3.4.1 to v3.4.2. No visible changes to the study details or page layout were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedA new publication citation by Chen D. et al. (J Immunother Cancer, 2020) was added to Publications, and the Erratum entry for the earlier paper was removed with the revision updated to v3.4.1.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Radiation in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page.